Novo Nordisk (NVO) has released an update.
Novo Nordisk A/S has announced a share repurchase program, with plans to buy back B shares worth up to DKK 20 billion over a 12-month period starting 6 February 2024. As of 21 June 2024, the company has repurchased 9,884,290 B shares at an average price of DKK 871.10, totaling DKK 8,610,201,494. This buyback is part of a larger strategy to manage capital and return value to shareholders.
For further insights into NVO stock, check out TipRanks’ Stock Analysis page.
